Methodology
What we show, where it comes from, and the rules we hold ourselves to. Every figure on the site traces to a primary source; nothing is estimated or guessed.
Sourcing
Events are detected directly from SEC EDGAR — the authoritative US filing system — by form type: Form 10 / 10-12B (spin-offs), DEFM14A (mergers), S-1 / F-1 (IPOs), Schedule 13E-3 (going private), Schedule 13D (activist), Schedule TO-T (tender offers), and 8-K item 1.03 (bankruptcy). Company financials come from SEC XBRL company-facts; ownership from Schedule 13D/13G and Form 4; short interest from FINRA; clinical trials from ClinicalTrials.gov; drug approvals from openFDA. All are public-domain or open data, free to redistribute.
How the pipeline works
The catalog is built and kept current by an automated pipeline that runs against SEC EDGAR — no manual data entry, no third-party data feeds:
- 1. Search. We query EDGAR full-text search for each relevant form type within a date window.
- 2. Group.Filings are grouped by the subject company's CIK (its permanent SEC identifier), so each company's event is one record.
- 3. Enrich.We pull the company's current name, ticker, exchange and SIC industry from the SEC submissions API.
- 4. Parse, strictly. For spin-offs we read the Information Statement for the parent, record/distribution dates and the share ratio — using tight, anchored patterns that skip rather than risk a wrong value.
- 5. Store. Each record is upserted keyed on (event type, company), newest filing wins, so re-scans and later amendments correct earlier data instead of duplicating it.
- 6. Refresh daily. A scheduled job re-scans a rolling window every day, catching new filings and amendments that finalise terms.
Coverage & completeness
We are deliberately honest about gaps rather than papering over them with estimates:
- Blank dates & ratios are normal.Many 10-12B filings are preliminary, so the distribution date or ratio isn't set yet — we show it blank until a filing states it, never a guess.
- Some companies have no current ticker.A spin-off that hasn't listed yet, or a target since acquired/delisted, simply has no ticker in SEC's data — we leave it empty rather than infer one.
- History reaches back to 2001. EDGAR full-text search covers 2001 onward; earlier filings need bulk-index ingestion, a planned extension.
- Expected dates are labelled.Where an upcoming spin-off's date isn't yet in a filing, any web-sourced expected date is shown as “~ est.” and kept strictly separate from SEC-confirmed dates.
Our rules
- Never guess.When a figure isn't cleanly available, we leave it blank — we never estimate or infer it.
- Everything is source-linked. Each event and datum points to the filing it came from, so you can verify it.
- No licensed prices. Stock prices, returns and index values require a paid redistribution licence, so we show none. We rely on fundamentals, ownership and structure instead — which the spin-off research weighs heavily.
- Facts, not advice. Signals are factors the research literature studies, not recommendations.
Spin-off signals
On each spin-off we surface the factors the academic and practitioner literature associates with spin-off outcomes — Greenblatt (You Can Be a Stock Market Genius, 1997); Cusatis, Miles & Woolridge (1993); Desai & Jain (1999); McConnell & Ovtchinnikov (2004). The composite “Spinoff Score” — a tally of favorable factors — follows the binary scorecard approach of Bülow & Mjörnemark (CBS, 2017) and Lindeborg & Falck (Lund, 2019), itself modeled on Piotroski's F-Score (2000). We implement the factors computable from free SEC data and deliberately omit the ones that need licensed data (analyst coverage; EV/EBIT, which needs a market price). Each is computed only from the company's own SEC filings:
- Focus-increasing
- Whether the spin-off enters a different sector than the parent (a pure-play). Focus-increasing spin-offs have historically outperformed diversifying ones (Desai-Jain).
- Size vs parent
- The spin-off's revenue relative to the parent's. Small spin-offs draw more forced index/institutional selling — the classic temporary-mispricing edge (Greenblatt).
- Leverage
- Liabilities ÷ assets. Parents sometimes load debt onto the spin-off; a clean balance sheet is favorable.
- Operating margin
- Profitability of the standalone business, from its own filings.
- Return on capital (ROCE)
- EBIT ÷ capital employed — the quality measure the spin-off scorecard research weighs most (Greenblatt; Bülow & Mjörnemark).
- Tax-basis report
- A Form 8937 accompanies tax-free §355 distributions — favorable for taxable holders.
- Insider buying
- Open-market purchases by new management (Form 4) — one of the strongest positive signals in the literature.
- Activist holder
- A 5%+ activist (Schedule 13D) is a potential value-unlock catalyst.
- Time since spin-off
- The documented premium concentrates in roughly the first one to three years.
The spin-off return premium is debated and weaker in recent samples (McConnell-Ovtchinnikov); these factors are descriptive, not a forecast or a recommendation.
Financial-health & forensic scores
On every company hub we compute four textbook scores from the company's own SEC XBRL figures — no market price, nothing estimated. Each is blank unless every input is cleanly present (we never guess), and each is a descriptive factor, not advice:
- Altman Z″ (distress)
- Book-value bankruptcy-distress score: 6.56·X1 + 3.26·X2 + 6.72·X3 + 1.05·X4, where X1–X4 are working capital, retained earnings, EBIT, and equity ÷ liabilities, scaled by assets. Above 2.6 = safe · 1.1–2.6 = grey · below 1.1 = distress. Uses no market cap, so it needs no licensed price (Altman, 1968/2006).
- Sloan accruals
- (net income − operating cash flow) ÷ assets. High positive accruals mean earnings aren't backed by cash — a classic earnings-quality red flag and restatement precursor (Sloan, 1996).
- Piotroski F-Score
- Counts how many of nine fundamental-health checks pass (profitability, leverage, efficiency), shown as passed / applicable. We use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged (Piotroski, 2000).
- Beneish M-Score
- An eight-ratio earnings-manipulation screen comparing the latest fiscal year with the prior one: M = −4.84 + 0.92·DSRI + 0.528·GMI + 0.404·AQI + 0.892·SGI + 0.115·DEPI − 0.172·SGAI + 4.679·TATA − 0.327·LVGI (indices of receivables/sales, gross margin, asset quality, sales growth, depreciation, SG&A, accruals and leverage). M above −1.78 historically flagged a higher likelihood of manipulation. It is a screen, not proof — we compute it only when all eight variables' inputs exist in both adjacent years and gross margins are positive (Beneish, 1999).
Questions about a specific figure? Every page links its source filing on SEC EDGAR. See also About and Data & API.